Search results

Filter

Filetype

Your search for "*" yielded 535176 hits

Graded error signals in eyeblink conditioning

Minimizing errors is an important aspect of learning. However, it is not enough merely to record if an error occurred. For efficient learning, information about the magnitude of errors is critical. Did my tennis swing completely miss the target or did I hit the ball, but not quite in the sweet spot? How can neurons – which have traditionally been thought of as binary units – signal the magnitude o

Dementia management in European primary care

Det beräknas att cirka 50 miljoner människor världen över har en demenssjukdom mot förväntade 152 miljoner år 2050 och enligt WHO är demenssjukdomar en prioriterad hälsopolitisk fråga. Primärvårdsläkares roll i upptäckt och behandling av tidig demens är troligen hälsoekonomiskt fördelaktig men primärvårdens handläggning av patienter med förmodad demens varierar stort. Syftet med denna avhandling vBackground: Around 50 million people worldwide have dementia and the prevalence is expected to increase to 152 million by 2050. According to the WHO, dementia is a priority health policy issue. The role of primary care physicians (PCPs) for timely dementia management can be cost-effective, yet PCP involvement in the management of patients with presumed or diagnosed dementia vary across Europe.Aim:

Dynamic-Electro Enhanced Chemotherapy brings relief to palliative patients with large tumour burden

Syftet med nuvarande arbetet är att genomföra en klinisk fallstudie som utvärderar begreppet Dynamisk-ElectroEnhanced Chemotherapy ™ (D-EECT). Tio patienter med plavocellkarcinom, åtta med bröstcancer och fem patienter med var och en som presenterade en annan typ av tumör, infördes i försöken initierade av fem olika cancercentra. Alla patienter fick Bleomycin och 2-3 behandlingstider med IQWave ™ The aim of the present work is to perform a clinical case study evaluating the concept of Dynamic-ElectroEnhanced Chemotherapy™ (D-EECT). Ten patients with squamous cell carcinoma, eight with breast cancer and five patients with each presenting a different type of tumour, were entered in the trials initiated by five different cancer centres. All the patients were given Bleomycin and 2 to 3 treatme

Den svenska modellen i fara? Fack, arbetsgivare och kollektivavtal på en föränderlig arbetsmarknad. : Statistik och analyser: facklig medlemsutveckling, organisationsgrad och kollektivavtalstäckning 2000-2023.

Den fackliga organisationsgradens utveckling i Sverige redovisas till och med 2018 (+ uppdatering t o m 2019), det vill säga andelen löntagare som är medlemmar i ett fackförbund. Denna rapport innehåller (1) en grundlig beskrivning av utvecklingen när det gäller organisationsgrad (på både fack- och arbetsgivarsidan), kollektivavtalstäckning och andra förändringar av partsmodellen; (2) en analys av

Direct observation of the S1 level of the carotenoid spheroidene using near-infrared femtosecond spectroscopy

In this work, we have determined the energy of the S1 state of the carotenoid spheroidene. The energy of this state is 13,400 ± 90 cm-1 at both 293 K and 186 K, showing that there is no temperature-induced shift of the S1 level. A discrepancy of about 800 cm-1 between the S1 energy determined here and that obtained from previous fluorescence and resonance Raman measurements is explained in terms o

Search for Higgs boson pair production in the bb¯ WW * decay mode at √s = 13 TeV with the ATLAS detector

A search for Higgs boson pair production in the bb¯ WW * decay mode is performed in the bb¯ ℓνqq final state using 36.1 fb −1 of proton-proton collision data at a centre-of-mass energy of 13 TeV recorded with the ATLAS detector at the Large Hadron Collider. No evidence of events beyond the background expectation is found. Upper limits on the non-resonant pp → HH production cross section of 10 pb a

Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour

Inflammatory myofibroblastic tumour (IMT) is a soft tissue tumour primarily affecting children and young adults. Approximately 50% of IMTs have gene fusions involving the receptor tyrosine kinase (RTK)-encoding ALK gene, providing a molecular rationale for treating IMT patients with unresectable tumours with tyrosine kinase inhibitors (TKI). However, a subset of IMT instead displays fusions affect